Anke Huber

420 total citations
11 papers, 350 citations indexed

About

Anke Huber is a scholar working on Molecular Biology, Genetics and Epidemiology. According to data from OpenAlex, Anke Huber has authored 11 papers receiving a total of 350 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 8 papers in Genetics and 3 papers in Epidemiology. Recurrent topics in Anke Huber's work include Virus-based gene therapy research (8 papers), RNA Interference and Gene Delivery (5 papers) and Viral Infectious Diseases and Gene Expression in Insects (5 papers). Anke Huber is often cited by papers focused on Virus-based gene therapy research (8 papers), RNA Interference and Gene Delivery (5 papers) and Viral Infectious Diseases and Gene Expression in Insects (5 papers). Anke Huber collaborates with scholars based in Germany, United States and Australia. Anke Huber's co-authors include Hildegard Büning, Michael Hallek, Ulrich Hacker, Luca Perabò, Liang Zhang, Nadja Meumann, Jim N. Burnell, Alexander Bürkle, Gerald Münch and Grant Stuchbury and has published in prestigious journals such as Hepatology, Virology and Molecular Therapy.

In The Last Decade

Anke Huber

11 papers receiving 342 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anke Huber Germany 10 248 242 56 38 37 11 350
Camilo Breton United States 10 255 1.0× 360 1.5× 57 1.0× 27 0.7× 56 1.5× 13 464
Mengqun Tan China 11 410 1.7× 436 1.8× 81 1.4× 48 1.3× 57 1.5× 20 524
John White United States 6 308 1.2× 576 2.4× 48 0.9× 29 0.8× 54 1.5× 9 659
Anna Narezkina United States 9 95 0.4× 180 0.7× 35 0.6× 41 1.1× 116 3.1× 14 349
Hiu Man Grisch‐Chan Switzerland 10 250 1.0× 612 2.5× 15 0.3× 36 0.9× 40 1.1× 16 686
Catherine K. Yang United States 7 156 0.6× 324 1.3× 64 1.1× 24 0.6× 11 0.3× 8 417
Cathleen Sookdeo United States 8 267 1.1× 290 1.2× 55 1.0× 50 1.3× 8 0.2× 9 425
Jian Dong United States 10 142 0.6× 251 1.0× 100 1.8× 72 1.9× 11 0.3× 16 465
Kankan Wang China 10 224 0.9× 398 1.6× 34 0.6× 31 0.8× 13 0.4× 19 468

Countries citing papers authored by Anke Huber

Since Specialization
Citations

This map shows the geographic impact of Anke Huber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anke Huber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anke Huber more than expected).

Fields of papers citing papers by Anke Huber

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anke Huber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anke Huber. The network helps show where Anke Huber may publish in the future.

Co-authorship network of co-authors of Anke Huber

This figure shows the co-authorship network connecting the top 25 collaborators of Anke Huber. A scholar is included among the top collaborators of Anke Huber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anke Huber. Anke Huber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Hösel, Marianna, Anke Huber, Julie Lucifora, et al.. (2017). Autophagy determines efficiency of liver‐directed gene therapy with adeno‐associated viral vectors. Hepatology. 66(1). 252–265. 36 indexed citations
2.
Büning, Hildegard, Anke Huber, Liang Zhang, Nadja Meumann, & Ulrich Hacker. (2015). Engineering the AAV capsid to optimize vector–host-interactions. Current Opinion in Pharmacology. 24. 94–104. 86 indexed citations
3.
Pasquale, Giovanni Di, Fernando Larcher, Matthias Rübsam, et al.. (2014). Tropism-modified AAV Vectors Overcome Barriers to Successful Cutaneous Therapy. Molecular Therapy. 22(5). 929–939. 41 indexed citations
4.
Märsch, Stephan, Anke Huber, Michael Hallek, Hildegard Büning, & Luca Perabò. (2010). A Novel Directed Evolution Method to Enhance Cell-Type Specificity of Adeno-Associated Virus Vectors. Combinatorial Chemistry & High Throughput Screening. 13(9). 807–812. 9 indexed citations
5.
Pozzoli, Ombretta, Anke Huber, Daniele Avitabile, et al.. (2010). Gene transfer into human cord blood−derived CD34+ cells by adeno-associated viral vectors. Experimental Hematology. 38(9). 707–717. 16 indexed citations
6.
Huber, Anke, et al.. (2009). Optimization of stealth adeno-associated virus vectors by randomization of immunogenic epitopes. Virology. 397(1). 167–175. 46 indexed citations
7.
Bouças, Jorge, Anke Huber, Luca Perabò, et al.. (2009). Engineering adeno‐associated virus serotype 2‐based targeting vectors using a new insertion site‐position 453‐and single point mutations. The Journal of Gene Medicine. 11(12). 1103–1113. 43 indexed citations
8.
Kunze, Melanie, et al.. (2009). Efficient gene transfer to periodontal ligament cells and human gingival fibroblasts by adeno-associated virus vectors. Journal of Dentistry. 37(7). 502–508. 13 indexed citations
9.
Rady, Peter L., Martin Hergersberg, Anke Huber, et al.. (2008). Epidermodysplasia Verruciformis in a HIV-Positive Patient Homozygous for the c917A→T Polymorphism in the <i>TMC8/EVER2 </i>Gene. Dermatology. 218(2). 114–118. 14 indexed citations
10.
Büning, Hildegard, Luca Perabò, Anke Huber, Stephan Märsch, & Michael Hallek. (2008). Artificial Evolution with Adeno-Associated Viral Libraries. Combinatorial Chemistry & High Throughput Screening. 11(2). 118–126. 11 indexed citations
11.
Huber, Anke, Grant Stuchbury, Alexander Bürkle, Jim N. Burnell, & Gerald Münch. (2006). Neuroprotective Therapies for Alzheimers Disease. Current Pharmaceutical Design. 12(6). 705–717. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026